XIAP-mediated protection of H460 lung cancer cells against cisplatin

被引:36
作者
Cheng, Yow-Jyun [1 ]
Jiang, Hang-Shiang [2 ]
Hsu, Shih-Lan [3 ]
Lin, Li-Chiung [1 ]
Wu, Chieh-Liang [1 ,4 ]
Ghanta, Vithal K. [5 ]
Hsueh, Chi-Mei [1 ]
机构
[1] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan
[2] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan
[3] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan
[4] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan
[5] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA
关键词
NSCLC; Cisplatin; XIAP; Caspase; 3; Drug resistance; DRUG-INDUCED APOPTOSIS; BCL-2; FAMILY; DEATH; PROTEINS; EXPRESSION; CHEMOTHERAPY; ACTIVATION; INHIBITOR; OMI/HTRA2; SYSTEM;
D O I
10.1016/j.ejphar.2009.11.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Molecular mechanism(s) responsible for drug resistance of non-small cell lung cancer (NSCLC) cells to cisplatin was investigated. Results showed that cisplatin (50 mu M)-induced cell death (apoptosis) was more significant in CH27 and A549 cell lines than in H460. The high protein levels of X-linked inhibitor-of-apoptosis protein (XIAP) observed in H460 cells appeared to play a key role in the regulation of cisplatin resistance of H460 cells. XIAP can bind to and suppress the activities of caspase 3 in H460 cells and lead to apoptosis inhibition of these cells. Blockade of XIAP activity by Embelin (XIAP inhibitor) or siRNA has increased caspase 3 activities and promoted cisplatin-induced cell death of H460 cells. The results indicate a therapeutic value of Embelin and/or XIAP siRNA in the control of cisplatin-resistant NSCLC cells (H460). (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 34 条
[1]   THE NUMBER OF PLATINUM ATOMS BINDING TO DNA, RNA AND PROTEIN MOLECULES OF HELA-CELLS TREATED WITH CISPLATIN AT ITS MEAN LETHAL CONCENTRATION [J].
AKABOSHI, M ;
KAWAI, K ;
MAKI, H ;
AKUTA, K ;
UJENO, Y ;
MIYAHARA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (05) :522-526
[2]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[3]   Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice [J].
Aneja, Ritu ;
Zhou, Jun ;
Zhou, Binfei ;
Chandra, Ramesh ;
Joshi, Harish C. .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (09) :2366-2377
[4]   Cisplatin nephrotoxicity [J].
Arany, I ;
Safirstein, RL .
SEMINARS IN NEPHROLOGY, 2003, 23 (05) :460-464
[5]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[6]   Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells [J].
Cilenti, L ;
Kyriazis, GA ;
Soundarapandian, MM ;
Stratico, V ;
Yerkes, A ;
Park, KM ;
Sheridan, AM ;
Alnemri, ES ;
Bonventre, JV ;
Zervos, AS .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 288 (02) :F371-F379
[7]   IAP family proteins - suppressors of apoptosis [J].
Deveraux, QL ;
Reed, TC .
GENES & DEVELOPMENT, 1999, 13 (03) :239-252
[8]  
Eguchi Y, 1997, CANCER RES, V57, P1835
[9]  
Ferreira CG, 2000, CLIN CANCER RES, V6, P203
[10]  
Fry WA, 1996, CANCER, V77, P1947, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1947::AID-CNCR27>3.0.CO